Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
The number of gout patients is rising, with an estimated 8.3 million American adults diagnosed with gout—but only 10 percent of them are being properly treated, according to the Gout & Uric Acid Education Society. To heighten awareness and knowledge about gout and to lead to earlier diagnosis and treatment, the society has released two new comprehensive kits to educate patients and provide consistent information for medical professionals. The release of the Take a Stand on Gout Patient Education Kit and Medical Professional Information Kit coincides with Gout Awareness Day, an annual commemoration on May 22 to call attention to the growing incidence of gout and to enhance knowledge so as to improve patient outcomes. Both kits provide new, substantial information about gout from specialists, who treat gout patients every day.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61805-gout-uric-acid-education-society-take-a-stand-on-gout-new-information-kits
Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and their handbags – the one item they do not leave home without – and urges women to take the Handbags & Hearts pledge to carry aspirin at all times to be prepared for a sudden heart attack. Being prepared by carrying aspirin, knowing the symptoms of heart attack and not putting off calling 911 if a heart attack is suspected, can be the difference between life and death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61582-bayer-healthcare-vanessa-williams-handbags-and-hearts-pledge-carry-aspirin
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
More than 300 global leaders, health and development experts, vaccinators, celebrities, philanthropists, and business leaders will gather tomorrow in Abu Dhabi in the first Global Vaccine Summit to endorse the critical role that vaccines and immunization play in giving children a healthy start to life. Despite tremendous progress, one child still dies every 20 seconds from preventable diseases like pneumonia, rotavirus, measles, and meningitis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61396-bill-and-melinda-gates-foundation-first-global-vaccine-summit
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
Fusion-io and two-time USA Memory Champion Nelson Dellis are teaming up to showcase the importance of memory in our minds and our datacenters. While Fusion-io focuses on helping its customers scale the challenges in their datacenters, Nelson will be focused on scaling the challenges he will face on Mount Everest, including what happens to your memory under the extreme conditions found on the world's highest mountain.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60918-fusion-io-climb-for-memory
Addiction can destroy careers and ruin lives. It can be devastating to watch a loved one descend into addiction, and family members often can’t understand why an addict continues to use drugs or alcohol despite the ruinous consequences.
In a series of new videos at besmartbewell.com/addiction, leading experts explain how addiction affects the brain and offer insight into why it is so hard for addicts to stop using drugs and alcohol.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61017-be-smart-be-well-explores-the-science-of-addiction
The Ad Council is joining forces with BAM! Body and Mind and KIDZ BOP to premiere The Greatest Action Movie Ever (G.A.M.E), a kid-targeted film offering fun ways to channel the inner action hero and take steps towards a more active and nutritionally-balanced lifestyle. Starring Ryan Ochoa of the hit Disney XD series Pair of Kings, the first half of the six-minute long G.A.M.E. film will premiere on Sunday, April 14 on Disney XD as part of Disney’s Magic of Healthy Living, an initiative that inspires kids and families to lead healthier lifestyles. Audiences will then be directed to Centers for Disease Control and Prevention’s BAM! Body and Mind website, BAM.gov, to see the second part of the film and access additional health-related resources. The full-length film will also be featured on KIDZBOP.com and Disney.com.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61182-ad-council-mccann-bam-kidz-bop-help-fight-childhood-obesity
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
Under the leadership of the National Organization for Rare Disorders (NORD), the primary organization in the U.S. representing people with rare diseases, millions of Americans will gather tomorrow to observe the 5th annual Rare Disease Day. This international observance unites people around the globe to focus attention on the estimated 300 to 350 million patients worldwide afflicted with rare diseases and to recognize that their needs are a global public health concern. In the U.S., a rare disease is one that affects fewer than 200,000 Americans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60507-nord-rare-disease-day
